Intracameral triamcinolone acetonide after pediatric cataract surgery.

PURPOSE: To assess the use of preservative-free intracameral triamcinolone as an adjunct to topical steroidal agents after pediatric cataract surgery.

SETTING

Children's University Hospital, Dublin, Ireland.

DESIGN

Retrospective case series.

METHODS

From the 2008 to 2009, intracameral preservative-free triamcinolone 4 mg/0.1 mL (Triesence) was used immediately after cataract surgery. Clinical indices of anterior segment inflammation were assessed at 1, 7, 14, 21 days and at 6 weeks postoperatively.

RESULTS

There were no complications secondary to triamcinolone use in 36 eyes of 26 children. In all but 1 case, intracameral triamcinolone was highly effective in controlling postoperative inflammation after pediatric cataract surgery, resulting in quiet eyes with few inflammatory signs (grade 0 to 1).

CONCLUSION

Intracameral triamcinolone provided a safe and useful adjunct to topical steroid drops after pediatric cataract surgery.